Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Empaveli™ (pegcetacoplan) – New orphan drug approval
May 14, 2021 - The FDA announced the approval of Apellis’ Empaveli (pegcetacoplan), for the treatment of adult patients with paroxysmal nocturnal hemoglobinuria (PNH).
